Today, he's just put another notch on his acquisitions belt, but not long ago Jim Lackey was begging for that first customer as he attempted to introduce technology in a sector fond of sticky notes, faxes and phone calls.
Former U.S. Sen. Bill Frist (left) predicted 'we're going to spend more on healthcare', but four VCs told local execs that few investors know much about Nashville's healthcare track record -- unwelcome news for Kin Clinton's Woolsthorpe Technologies.
Making scientific discoveries that can survive the punishing path toward the market is hard enough. Now that the FDA has approved marketing that could save liver-cancer patients' lives, Pathfinder Therapeutics hopes local investors and the State of Tennessee can lend a hand. But, they're not holding their breath.